Actively Recruiting

All Genders
Healthy Volunteers
NCT05283993

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

Led by Peking University First Hospital · Updated on 2022-04-25

2000

Participants Needed

1

Research Sites

495 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The primary aim is to establish a prospective cohort of patients with plasma cell disorders (PCDs). All of the hospitalized PCD patients who are willing to sign the informed consent form (ICF) will be included in this study. Clinical characteristics, treatment options and responses will be collected. Peripheral blood, bone marrow aspirate and urine samples before and after the treatment will banked for future research. Our team will focus on the clinical and pathological features of PCDs, the correlation between the minimal residual disease (MRD) status and prognosis, and the role of Tumor Microenvironment (TME) in the pathogenesis and progress of PCDs.

CONDITIONS

Official Title

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

Who Can Participate

All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with a confirmed diagnosis of plasma cell disorders hospitalized at Peking University First Hospital (PKUFH)
  • Diagnosed with one of the following plasma cell disorders: monoclonal gammopathy of uncertain significance, smoldering myeloma, multiple myeloma, plasma cell leukemia, amyloidosis, light chain deposition disease, heavy chain deposition disease, Castleman's disease, POEMS syndrome, cryoglobulinemia, Monoclonal Gammopathy of Renal Significance (MGRS), or Monoclonal Gammopathy of Neurological Significance (MGNS)
  • Signed informed consent form to join the study
Not Eligible

You will not qualify if you...

  • Presence of significant comorbid conditions that may be life-threatening

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Peking University First Hospital

Beijing, China

Actively Recruiting

Loading map...

Research Team

B

Bo Tang, PhD

CONTACT

Y

Yujun Dong, M.D.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here